The synthesis and biological evaluation of 4-p-nitrobenzylthio-v-triazolo[4,5-d]pyridazine and imidazo[4,5-d]pyridazine ribosides as potential nucleoside transport inhibitors

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1725-1731

  Bussolari, Jacqueline C ^a   Stoeckler, Johanna D ^b,c   Panzica, Raymond P ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE;

ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; ERYTHROCYTE; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE; NUCLEOSIDE TRANSPORT;

EID: 0030272842     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00188-5     Document Type: Article

References (20)

1. 1. Presented in part at the 201st National Meeting of the American Chemical Society, Atlanta, Georgia, April 1991, MEDI 143.
2. 2. (a) Chen, S.-F.; Panzica, R. P. J. Heterocycl. Chem. 1982, 19, 285;
3. (b) Bussolari, J. C.; Kakarla, R.; Stoeckler, J. D.; Chen, S.-F.; Panzica, R. P. J. Med. Chem. 1993, 36, 4113.
4. 3. (a) Chen, S.-F.; Panzica, R. P. J. Heterocycl. Chem. 1981, 18, 303;
5. (b) Graves, B. J.; Hodgson, D. J.; Chen, S.-F.; Panzica, R. P. Heterocycles, 1981, 16, 9;
6. (c) Chen, S.-F.; Panzica, R. P. J. Org. Chem. 1981, 46, 2467.
7. 4. Naguib, F. N. M.; Iltzsch, M. H.; el Kouni, M. M.; Panzica, R. P.; el Kouni, M. H. Biochem. Pharmacol. 1995, 50, 1685.
8. 5. Belt, J. A.; Marina, N. M.; Phelps, D. A.; Crawford, C. R. Adv. Enzyme Regul. 1993, 33, 235.
9. 6. Paul, B.; Chen, M.F.; Paterson A.R.P. J. Med. Chem. 1975, 18, 968.
10. 7. Stoeckler, J. D.; Rosenfield, C. G.; Chu, S.-H.; Li, S.-Y.; Acton, E. M.; Ryan, K. J.; Parks, R. E., Jr. Biochem. Pharmacol. 1990, 40, 615.
11. 8. Elion, G. B. Fed. Proc. 1967, 26, 898.
12. 9. Benedict, W. F.; Baker, L.; Haroun, L.; Choi, E.; Ames, B. N. Cancer Res. 1977, 37, 2209.
13. 10. Kakarla, R.; Panzica, R. P. J. Chem. Soc., Perkin Trans. 1 1989, 1769.
14. 11. Montero, J.-L. G.; Bhat, G. A.; Panzica, R.P.; Townsend, L.B. J. Heterocycl. Chem. 1977, 14, 483.
15. 12. Jankowski, A. J.; Wise, D.S., Jr.; Townsend, L. B. Nucleosides Nucleotides 1989, 8, 339.
16. 13. Gagnier, R. P.; Halat, M. J.; Otter, B. A. J. Heterocycl. Chem. 1984, 21, 481.
17. 3c of the imidazo[4,5-d]pyridazine ring, per se, in the presence of excess alkylating agent, we found this not to be the case when this ring system was substituted on the N-1 of the five-membered ring portion of this heterocycle. This also holds true for the v-triazolo[4,5-d]pyridazine ring system.
18. 15. Stoeckler, J. D.; Rosenfield, C. G.; Chu, S.-H.; Li, S.-Y.; Acton, E. M.; Ryan, K. J.; Parks, R. E., Jr. Biochem. Pharmacol. 1990, 40, 615.
19. 16. Chen, S.-F.; Cleaveland, J. C.; Hollmann, A.; Weimann, M. C.; Parks, R. E., Jr.; Stoeckler, J. D. Cancer Res. 1986, 46, 3449.
20. 17. Paterson, A. R. P.; Harley, E. R.; Cass, C. E. Biochem. J. 1984, 224, 1001.